These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1701070)

  • 1. Hematopoietic growth factors: overview and clinical applications, Part II.
    Robinson BE; Quesenberry PJ
    Am J Med Sci; 1990 Oct; 300(4):237-44. PubMed ID: 1701070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic growth factors: overview and clinical applications, Part III.
    Robinson BE; Quesenberry PJ
    Am J Med Sci; 1990 Nov; 300(5):311-21. PubMed ID: 1700606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic growth factors: overview and clinical applications, Part I.
    Robinson BE; Quesenberry PJ
    Am J Med Sci; 1990 Sep; 300(3):163-70. PubMed ID: 2240007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunobiology of hematopoietic colony-stimulating factors: potential application to disease prevention in the bovine.
    Kehrli ME; Cullor JS; Nickerson SC
    J Dairy Sci; 1991 Dec; 74(12):4399-412. PubMed ID: 1724001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.
    Muszynski KW; Ruscetti FW; Heidecker G; Rapp U; Troppmair J; Gooya JM; Keller JR
    J Exp Med; 1995 Jun; 181(6):2189-99. PubMed ID: 7539043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic growth factors.
    Tabbara IA; Robinson BE
    Anticancer Res; 1991; 11(1):81-90. PubMed ID: 1708221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation and differentiation of myelodysplastic CD34+ cells in serum-free medium: response to individual colony-stimulating factors.
    Sawada K; Sato N; Tarumi T; Sakai N; Koizumi K; Sakurama S; Ieko M; Yasukouchi T; Koyanagawa Y; Yamaguchi M
    Br J Haematol; 1993 Mar; 83(3):349-58. PubMed ID: 7683482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of hematopoietic growth factors.
    Vose JM; Armitage JO
    J Clin Oncol; 1995 Apr; 13(4):1023-35. PubMed ID: 7535842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human hematopoietic growth factors in the treatment of cytopenias.
    Grosh WW; Quesenberry PJ
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 2):S25-38. PubMed ID: 1728985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic growth factors: biology and clinical application.
    Gabrilove JL; Jakubowski A
    J Natl Cancer Inst Monogr; 1990; (10):73-7. PubMed ID: 1693284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status of the clinical application of hematopoietic growth factors in oncology].
    Karthaus M; Ganser A
    Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.
    Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the biology of human hematopoietic growth factors.
    Coulombel L
    Nouv Rev Fr Hematol (1978); 1989; 31(2):93-6. PubMed ID: 2671934
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematologic effects of interleukin-1 beta, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor in tumor-bearing mice treated with fluorouracil.
    Moore MA; Stolfi RL; Martin DS
    J Natl Cancer Inst; 1990 Jun; 82(12):1031-7. PubMed ID: 1693405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colony-stimulating factors. Present status and future potential.
    Fox RM
    Pharmacoeconomics; 1994; 6 Suppl 2():1-8. PubMed ID: 10155591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical use of hematopoietic growth factors.
    Appelbaum FR
    Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage colony-stimulating factor in cooperation with transforming growth factor-beta1 induces the differentiation of CD34+ hematopoietic progenitor cells into Langerhans cells under serum-free conditions without granulocyte-macrophage colony-stimulating factor.
    Mollah ZU; Aiba S; Nakagawa S; Hara M; Manome H; Mizuashi M; Ohtani T; Yoshino Y; Tagami H
    J Invest Dermatol; 2003 Feb; 120(2):256-65. PubMed ID: 12542531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hematopoietic cytokines: an overview.
    Murphy MJ
    Toxicol Pathol; 1993; 21(2):229-30. PubMed ID: 7692584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.